يحاول ذهب - حر
7Th DIA India Pharmacovigilance Conference Held In Mumbai
May 01-15, 2019
|Express Pharma
The two-day conference discussed the latest trends and developments in pharmacovigilance, drug safety and medical affairs and the impact of innovations like artificial intelligence, machine learning, automation and real-world evidence on driving better safety outcomes
-
DIA INDIA recently organised the 7th Pharmacovigilance Conference in Mumbai on the theme ‘Transforming Clinical Safety and Pharmacovigilance.’ The two-day conference discussed and explored the latest trends and developments in the space of pharmacovigilance, drug safety and medical affairs and the impact of innovations like artificial intelligence, machine learning, automation and real-world evidence on driving better safety outcomes. The programme, created under the expert guidance of Moin Don, President and CEO, PVCON
Consulting as programme chair, Dr Krishna Bahadursingh, Fellow of the Faculty of Pharmaceutical Medicine (UK) as co-chair , and a stellar programme committee of senior industry executives from the Indian healthcare fraternity, was successful in fostering international exchange of actionable regulatory, medical and commercial insights to advance drug safety and pharmacovigilance.
With seven individual sessions, over 15 presentations and two panel discussions, the 7thPharmacovigilance conference convened 31 distinguished national and international subject matter experts from regulatory, industry,and academia. It engaged global decision makers and influencers with more than 200 professionals participating from the pharmaceutical, biotechnology services and academic global communities .
هذه القصة من طبعة May 01-15, 2019 من Express Pharma.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Express Pharma
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Translate
Change font size
